Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Irritable Bowel Syndrome

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    February 2024
  1. HO FF, Sun H, Zheng H, Wong DCN, et al
    Association of healthy lifestyle behaviours with incident irritable bowel syndrome: a large population-based prospective cohort study.
    Gut. 2024 Feb 20:gutjnl-2023-331254. doi: 10.1136/gutjnl-2023-331254.
    PubMed     Abstract available


  2. FORD AC
    Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?
    Gut. 2024 Feb 1:gutjnl-2024-331927. doi: 10.1136/gutjnl-2024-331927.
    PubMed    


    January 2024
  3. DECRAECKER L, De Looze D, Hirsch DP, De Schepper H, et al
    Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial.
    Gut. 2024 Jan 8:gutjnl-2023-331634. doi: 10.1136/gutjnl-2023-331634.
    PubMed     Abstract available


    November 2023
  4. TUN HM, Peng Y, Massimino L, Sin ZY, et al
    Gut virome in inflammatory bowel disease and beyond.
    Gut. 2023 Nov 10:gutjnl-2023-330001. doi: 10.1136/gutjnl-2023-330001.
    PubMed     Abstract available


    October 2023
  5. JUZENAS S, Ellinghaus D, Sanna S, Franke A, et al
    Mendelian randomisation shows diverticular disease and irritable bowel syndrome increase the risk of haemorrhoidal disease.
    Gut. 2023 Oct 9:gutjnl-2023-330364. doi: 10.1136/gutjnl-2023-330364.
    PubMed    


    August 2023
  6. KONINGS B, Villatoro L, Van den Eynde J, Barahona G, et al
    Gastrointestinal syndromes preceding a diagnosis of Parkinson's disease: testing Braak's hypothesis using a nationwide database for comparison with Alzheimer's disease and cerebrovascular diseases.
    Gut. 2023 Aug 24:gutjnl-2023-329685. doi: 10.1136/gutjnl-2023-329685.
    PubMed     Abstract available


    March 2023
  7. DAI C, Huang YH, Jiang M
    Post-COVID-19 irritable bowel syndrome.
    Gut. 2023 Mar 10:gutjnl-2023-329714. doi: 10.1136/gutjnl-2023-329714.
    PubMed    


  8. ZAMFIR-TARANU A, Loscher BS, Husein DM, Hoter A, et al
    Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients.
    Gut. 2023 Mar 6:gutjnl-2023-329695. doi: 10.1136/gutjnl-2023-329695.
    PubMed    


    February 2023
  9. BULMER D
    Neuroactive changes in the bowel of patients with IBS on low FODMAP diet: another piece of the puzzle.
    Gut. 2023 Feb 3:gutjnl-2022-329184. doi: 10.1136/gutjnl-2022-329184.
    PubMed    


  10. HOUDEVILLE C, Chartier S, Delaye M, Fabiani B, et al
    White small bowel in a patient with chronic diarrhoea.
    Gut. 2023;72:225-324.
    PubMed    


    January 2023
  11. ZHU Z, Chen X, Wang C, Zhang S, et al
    Haemorrhoidal disease reduces the risk of diverticular disease and irritable bowel syndrome: a Mendelian randomisation study.
    Gut. 2023 Jan 24:gutjnl-2022-329307. doi: 10.1136/gutjnl-2022-329307.
    PubMed    


  12. VANUYTSEL T, Bercik P, Boeckxstaens G
    Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders.
    Gut. 2023 Jan 19:gutjnl-2020-320633. doi: 10.1136/gutjnl-2020-320633.
    PubMed     Abstract available


  13. BOUSABA J, Zheng T, Dilmaghani S, Johnson S, et al
    Effect of rapid colonic transit on stool microbiome and short-chain fatty acids in diarrhoea-predominant irritable bowel syndrome.
    Gut. 2023 Jan 19:gutjnl-2022-329359. doi: 10.1136/gutjnl-2022-329359.
    PubMed    


    December 2022
  14. TUCK CJ, Abu Omar A, De Palma G, Osman S, et al
    Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain.
    Gut. 2022 Dec 13:gutjnl-2022-327260. doi: 10.1136/gutjnl-2022-327260.
    PubMed     Abstract available


  15. MARASCO G, Cremon C, Barbaro MR, Cacciari G, et al
    Post COVID-19 irritable bowel syndrome.
    Gut. 2022 Dec 9:gutjnl-2022-328483. doi: 10.1136/gutjnl-2022-328483.
    PubMed     Abstract available


    October 2022
  16. CAMILLERI M, Boeckxstaens G
    Irritable bowel syndrome: treatment based on pathophysiology and biomarkers.
    Gut. 2022 Oct 28. pii: gutjnl-2022-328515. doi: 10.1136/gutjnl-2022-328515.
    PubMed     Abstract available


  17. PETITFILS C, Maurel S, Payros G, Hueber A, et al
    Identification of bacterial lipopeptides as key players in IBS.
    Gut. 2022 Oct 14. pii: gutjnl-2022-328084. doi: 10.1136/gutjnl-2022-328084.
    PubMed     Abstract available


  18. TACK J, Van den Houte K, Carbone F
    Role of the DOMINO diet application for managing IBS in primary care and beyond.
    Gut. 2022 Oct 13. pii: gutjnl-2022-328315. doi: 10.1136/gutjnl-2022-328315.
    PubMed    


    September 2022
  19. JALANKA J, Gunn D, Singh G, Krishnasamy S, et al
    Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery.
    Gut. 2022 Sep 28. pii: gutjnl-2021-326828. doi: 10.1136/gutjnl-2021-326828.
    PubMed     Abstract available


  20. BALSIGER LM, Van den Houte K, Zheng T, Toth J, et al
    Genetic analyses of treatment response in primary care IBS, a pilot study.
    Gut. 2022 Sep 23. pii: gutjnl-2022-328430. doi: 10.1136/gutjnl-2022-328430.
    PubMed    


    July 2022
  21. CAMILLERI M
    Fifty-point IBS-SSS responders but persistence of moderate severity IBS in over 40% of those on diet.
    Gut. 2022 Jul 26. pii: gutjnl-2022-328211. doi: 10.1136/gutjnl-2022-328211.
    PubMed    


    June 2022
  22. HOWELL CA, Kemppinen A, Allgar V, Dodd M, et al
    Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D).
    Gut. 2022 Jun 27. pii: gutjnl-2022-327293. doi: 10.1136/gutjnl-2022-327293.
    PubMed     Abstract available


  23. REJ A, Sanders DS, Aziz I
    Further research needed to determine first-line therapy for IBS in primary care.
    Gut. 2022 Jun 22. pii: gutjnl-2022-328047. doi: 10.1136/gutjnl-2022-328047.
    PubMed    


    May 2022
  24. CAMILLERI M, Carlson P, BouSaba J, McKinzie S, et al
    Comparison of biochemical, microbial and mucosal mRNA expression in bile acid diarrhoea and irritable bowel syndrome with diarrhoea.
    Gut. 2022 May 17. pii: gutjnl-2022-327471. doi: 10.1136/gutjnl-2022-327471.
    PubMed     Abstract available


    April 2022
  25. CARBONE F, Van den Houte K, Besard L, Tack C, et al
    Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.
    Gut. 2022 Apr 28. pii: gutjnl-2021-325821. doi: 10.1136/gutjnl-2021-325821.
    PubMed     Abstract available


    November 2021
  26. VERVIER K, Moss S, Kumar N, Adoum A, et al
    Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.
    Gut. 2021 Nov 22. pii: gutjnl-2021-325177. doi: 10.1136/gutjnl-2021-325177.
    PubMed     Abstract available


  27. GIBSON PR, Halmos EP
    The FODMAP diet: more than just a symptomatic therapy?
    Gut. 2021 Nov 22. pii: gutjnl-2021-326284. doi: 10.1136/gutjnl-2021-326284.
    PubMed    


  28. BALSIGER LM, Tack J
    Letter to the editor: prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.
    Gut. 2021 Nov 10. pii: gutjnl-2021-326252. doi: 10.1136/gutjnl-2021-326252.
    PubMed    


    October 2021
  29. FOLEY A, Halmos EP, Husein DM, Fehily SR, et al
    Adult sucrase-isomaltase deficiency masquerading as IBS.
    Gut. 2021 Oct 6. pii: gutjnl-2021-326153. doi: 10.1136/gutjnl-2021-326153.
    PubMed    


    September 2021
  30. VERBEKE K
    Combining dietary fibres to reduce intestinal gas production in patients with IBS.
    Gut. 2021 Sep 23. pii: gutjnl-2021-325618. doi: 10.1136/gutjnl-2021-325618.
    PubMed    


  31. BOJARSKI C, Tangermann P, Barmeyer C, Buchkremer J, et al
    Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.
    Gut. 2021 Sep 20. pii: gutjnl-2021-325181. doi: 10.1136/gutjnl-2021-325181.
    PubMed     Abstract available


    August 2021
  32. SO D, Gibson PR, Muir JG, Yao CK, et al
    Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine.
    Gut. 2021 Aug 20. pii: gutjnl-2021-324891. doi: 10.1136/gutjnl-2021-324891.
    PubMed     Abstract available


  33. BLACK CJ, Staudacher HM, Ford AC
    Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.
    Gut. 2021 Aug 10. pii: gutjnl-2021-325214. doi: 10.1136/gutjnl-2021-325214.
    PubMed     Abstract available


  34. GUNN D, Abbas Z, Harris HC, Major G, et al
    Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies.
    Gut. 2021 Aug 5. pii: gutjnl-2021-324784. doi: 10.1136/gutjnl-2021-324784.
    PubMed     Abstract available


    April 2021
  35. VASANT DH, Paine PA, Black CJ, Houghton LA, et al
    British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.
    Gut. 2021 Apr 26. pii: gutjnl-2021-324598. doi: 10.1136/gutjnl-2021-324598.
    PubMed     Abstract available


  36. BOLTE LA, Vich Vila A, Imhann F, Collij V, et al
    Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
    Gut. 2021 Apr 2. pii: gutjnl-2020-322670. doi: 10.1136/gutjnl-2020-322670.
    PubMed     Abstract available


    March 2021
  37. EL-SALHY M
    FMT in IBS: how cautious should we be?
    Gut. 2021;70:626-628.
    PubMed    


    February 2021
  38. CAMILLERI M
    FMT in IBS: a call for caution.
    Gut. 2021;70:431.
    PubMed    


    December 2020
  39. SPILLER RC, Jalanka J
    Brachyspira and IBS with diarrhoea: a Helicobacter pylori moment?
    Gut. 2020 Dec 24. pii: gutjnl-2020-323370. doi: 10.1136/gutjnl-2020-323370.
    PubMed    


    November 2020
  40. JABBAR KS, Dolan B, Eklund L, Wising C, et al
    Association between Brachyspira and irritable bowel syndrome with diarrhoea.
    Gut. 2020 Nov 11. pii: gutjnl-2020-321466. doi: 10.1136/gutjnl-2020-321466.
    PubMed     Abstract available


    October 2020
  41. MASSIER L, Chakaroun R, Kovacs P, Heiker JT, et al
    Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability.
    Gut. 2020 Oct 9. pii: gutjnl-2020-323026. doi: 10.1136/gutjnl-2020-323026.
    PubMed    


  42. PERNA E, Aguilera-Lizarraga J, Florens MV, Jain P, et al
    Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS.
    Gut. 2020 Oct 6. pii: gutjnl-2020-321530. doi: 10.1136/gutjnl-2020-321530.
    PubMed     Abstract available


    September 2020
  43. BLACK CJ, Craig O, Gracie DJ, Ford AC, et al
    Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322519. doi: 10.1136/gutjnl-2020-322519.
    PubMed     Abstract available


    May 2020
  44. REJ A, Buckle RL, Shaw CC, Trott N, et al
    Is CBT the dominant non-drug IBS treatment? The rise of dietary therapies.
    Gut. 2020 May 19. pii: gutjnl-2020-321658. doi: 10.1136/gutjnl-2020-321658.
    PubMed    


  45. POTTER MDE, Goodsall TM, Walker MM, Talley NJ, et al
    Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience.
    Gut. 2020;69:966.
    PubMed    


    April 2020
  46. BLACK CJ, Thakur ER, Houghton LA, Quigley EMM, et al
    Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis.
    Gut. 2020 Apr 10. pii: gutjnl-2020-321191. doi: 10.1136/gutjnl-2020-321191.
    PubMed     Abstract available


    March 2020
  47. JEFFERY IB, O'Herlihy E, Shanahan F, O' Toole PW, et al
    Microbiome alterations in IBS.
    Gut. 2020 Mar 5. pii: gutjnl-2020-320919. doi: 10.1136/gutjnl-2020-320919.
    PubMed    


    February 2020
  48. BARBARA G, Ianiro G
    Faecal microbial transplantation in IBS: ready for prime time?
    Gut. 2020 Feb 26. pii: gutjnl-2019-320411. doi: 10.1136/gutjnl-2019-320411.
    PubMed    


  49. BARBARO MR, Cremon C, Morselli-Labate AM, Di Sabatino A, et al
    Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity.
    Gut. 2020 Feb 14. pii: gutjnl-2019-319281. doi: 10.1136/gutjnl-2019-319281.
    PubMed     Abstract available


    January 2020
  50. BLACK CJ, Burr NE, Camilleri M, Earnest DL, et al
    Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
    Gut. 2020;69:74-82.
    PubMed     Abstract available


  51. EDOGAWA S, Edwinson AL, Peters SA, Chikkamenahalli LL, et al
    Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Gut. 2020;69:62-73.
    PubMed     Abstract available


    December 2019
  52. EL-SALHY M, Hatlebakk JG, Gilja OH, Brathen Kristoffersen A, et al
    Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
    Gut. 2019 Dec 18. pii: gutjnl-2019-319630. doi: 10.1136/gutjnl-2019-319630.
    PubMed     Abstract available


  53. LIU H, Han M, Li SC, Tan G, et al
    Resilience of human gut microbial communities for the long stay with multiple dietary shifts.
    Gut. 2019;68:2254-2255.
    PubMed    


    November 2019
  54. ONG J, Swift C, Allwood I, Norman R, et al
    Chronic diarrhoea: the indications for lower GI endoscopy when functional bowel disease is suspected.
    Gut. 2019;68:2100.
    PubMed    


    October 2019
  55. HUGERTH LW, Andreasson A, Talley NJ, Forsberg AM, et al
    No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.
    Gut. 2019 Oct 10. pii: gutjnl-2019-318717. doi: 10.1136/gutjnl-2019-318717.
    PubMed     Abstract available


    September 2019
  56. TALLEY NJ, Holtmann GJ, Jones M, Koloski NA, et al
    Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity.
    Gut. 2019 Sep 28. pii: gutjnl-2019-318664. doi: 10.1136/gutjnl-2019-318664.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.